Stocks · Health care · Services-Commercial Physical & Biological Research

OmniAb, Inc.

OABI Clue Score25
United States Fiscal year ends December CIK 0001846253 Results filed 30 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Charles S Berkman
7 Apr 2026
Chief Legal Officer
Sold after exercise
7,157
$1.49
$10.66K
Kurt A Gustafson
7 Apr 2026
Executive VP, Finance and CFO
Sold after exercise
6,913
$1.49
$10.30K
Matthew W Foehr
7 Apr 2026
President and CEO
Sold after exercise
19,244
$1.49
$28.67K
Matthew W Foehr
18 Feb 2026
President and CEO
Sold after exercise
30,843
$1.71
$52.74K
Kurt A Gustafson
18 Feb 2026
Executive VP, Finance and CFO
Sold after exercise
9,301
$1.71
$15.90K
Charles S Berkman
18 Feb 2026
Chief Legal Officer
Sold after exercise
9,673
$1.71
$16.54K
Charles S Berkman
17 Feb 2026
Chief Legal Officer
Sell
6,990
$1.70
$11.88K
Kurt A Gustafson
17 Feb 2026
Executive VP, Finance and CFO
Sell
6,828
$1.70
$11.61K
Matthew W Foehr
17 Feb 2026
President and CEO
Sell
20,754
$1.70
$35.28K
Matthew W Foehr
8 Dec 2025
President and CEO
Sell
13,666
$1.96
$26.79K
Kurt A Gustafson
8 Dec 2025
Executive VP, Finance and CFO
Sell
23,922
$1.96
$46.89K
Charles S Berkman
8 Dec 2025
Chief Legal Officer
Sell
8,044
$1.96
$15.77K
John L Higgins
7 Nov 2025
Director
Buy
41,038
$1.38
$56.63K
John L Higgins
6 Nov 2025
Director
Buy
36,223
$1.41
$51.07K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 484,765
History held since 3 Nov 2022